Latest Connected Care News

Page 1 of 3
BD finished fiscal 2026 with higher revenue, adjusted earnings and cash generation, while setting low single-digit growth expectations for the year ahead. Its proposed US$19 billion US investment adds scale to the strategy, but remains tied to milestones and future implementation.
Ada Torres
Ada Torres
5 Nov 2026
ResMed has delivered a stronger first quarter for fiscal 2027, with revenue up 6% to US$1.415 billion and net income rising 20% to US$418 million. The headline result was helped by a preliminary gain on the MatrixCare sale, while the core Sleep and Breathing Health business continued to expand.
Ada Torres
Ada Torres
2 Nov 2026
Spacetalk Ltd reported a 17% revenue decline in FY26 amid a strategic reset, but mobile revenue grew 16% as the company pivots to a software-led family safety platform supported by new telco partnerships.
Sophie Babbage
Sophie Babbage
28 Aug 2026
Talius has secured a substantial $850,000 purchase order from New Zealand’s Hato Hone St John, adding 8,000 devices and boosting its recurring revenue by $55,000 annually.
Ada Torres
Ada Torres
10 Aug 2026
ResMed is offloading its MatrixCare business in a $490 million cash deal, reinforcing its strategic pivot towards high-growth sleep and connected care markets. The sale proceeds will fuel shareholder returns and innovation investments.
Victor Sage
Victor Sage
8 July 2026
Oceania Healthcare Limited has delivered a standout FY26 with 16% higher sales, 20% EBITDA growth, and a 19% reduction in net debt, setting the stage for positive cash flow in FY27 despite no dividend declared this year.
Ada Torres
Ada Torres
22 May 2026
Vitasora has launched its proprietary vCare EMR platform, cutting SaaS costs by over 90% and nearly doubling patient enrolments in April. The company targets cashflow breakeven in H2 2026 as enrolment momentum builds.
Ada Torres
Ada Torres
18 May 2026
Oneview Healthcare reported a robust 21% increase in revenue for FY2025, driven by recurring revenue growth and new customer acquisitions. The company is advancing AI-powered solutions and targeting operational breakeven in 2026.
Victor Sage
Victor Sage
12 Feb 2026
Resmed Inc. posted robust Q2 FY2026 results, with revenue climbing 11% to $1.4 billion and a 16% rise in non-GAAP earnings per share, underpinned by strong global demand and operational efficiencies.
Ada Torres
Ada Torres
30 Jan 2026
Vitasora Health Limited reported a significant 22% increase in daily clinical billing productivity for the December 2025 quarter, alongside a 17% rise in operating revenue. With new CMS reimbursement policies now in effect, the company anticipates a further 10–20% revenue uplift in 2026.
Ada Torres
Ada Torres
29 Jan 2026
Vitasora Health has completed an A$11 million capital raise, including a cornerstone investment, bolstering its balance sheet to support ambitious growth in the US healthcare market. The company targets cash flow breakeven by the end of FY2026 amid expanding patient programs and new partnerships.
Ada Torres
Ada Torres
16 Jan 2026
Vitasora Health has secured AU$3.56 million from a cornerstone investor, issuing over 118 million shares, while confirming compliance with key regulatory disclosure obligations.
Ada Torres
Ada Torres
2 Dec 2025

Browse the archive

Full archive